Table 2.
Parameter | Included (n = 20) | Lost to Follow Up (n = 6) | p |
---|---|---|---|
Median Age at surgery | 25 (13–63) years | 40 (10-61) years | 0.7 T |
Follow up after surgery | 5 (1–17) years | 3 (0-8) months | 0.007 T |
Sex | |||
Male/Female | 9/11 | 2/4 | 0.6 # |
Oncological status | |||
No evidence of disease | 12 (60%) | 0 (0%) | 0.01 # |
Dead of disease | 7 (35%) | 6 (100%) | 0.005 # |
Dead of other cause | 1 (5%) | 0 (0%) | |
Conversion to hemipelvectomy | 3 (15%) | 3 (50%) | 0.07 # |
Infection | 9 (45%) | 3 (50%) | 0.8 # |
Thromboembolic event | 5 (25%) | 2 (33%) | 0.7 # |
Conservative/surgical treatment | 2/3 | 0/2 |
Differences between groups tested via, T = T-test, # = Chi-square-test.